Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Purification and partial characterization of human immunodeficiency virus type 2 reverse transcriptase.

A L DeVico1, T D Copeland, F D Veronese

  • 1Department of Cell Biology, Bionetics Research, Inc., Rockville, MD 20850.

AIDS Research and Human Retroviruses
|February 1, 1989
PubMed
Summary

Researchers developed a novel antibody targeting human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT). This antibody also neutralizes HIV-1 and HIV-2 RT activity, identifying key viral proteins.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Screening test for HTLV-III (AIDS agent) antibodies: specificity, sensitivity, and applications.

JAMA·2014
Same author

Progress toward the development of a bacterial vaccine vector that induces high-titer long-lived broadly neutralizing antibodies against HIV-1.

FEMS immunology and medical microbiology·2003
Same author

Immunogenicity of DNA vaccines that direct the coincident expression of the 120 kDa glycoprotein of human immunodeficiency virus and the catalytic domain of cholera toxin.

Vaccine·2003
Same author

Mucosal and systemic HIV-1 Env-specific CD8(+) T-cells develop after intragastric vaccination with a Salmonella Env DNA vaccine vector.

Vaccine·2001
Same author

Antigenic properties of the human immunodeficiency virus envelope during cell-cell fusion.

Journal of virology·2001
Same author

Perforin-low memory CD8+ cells are the predominant T cells in normal humans that synthesize the beta -chemokine macrophage inflammatory protein-1beta.

Proceedings of the National Academy of Sciences of the United States of America·2001

Area of Science:

  • Virology
  • Immunology
  • Molecular Biology

Background:

  • Human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) is a critical enzyme for viral replication.
  • Developing specific antibodies against HIV-1 RT can aid in understanding viral mechanisms and potential therapeutic strategies.
  • Conserved regions in viral proteins across different strains, like HIV-1 and HIV-2, present opportunities for broad-spectrum targeting.

Purpose of the Study:

  • To generate and characterize a monospecific antibody against a conserved region of HIV-1 reverse transcriptase.
  • To evaluate the antibody's cross-reactivity and inhibitory effects on HIV-2 reverse transcriptase.
  • To identify and isolate viral proteins associated with reverse transcriptase and RNAse H activities in HIV-2.

Main Methods:

Related Experiment Videos

  • Production of a rabbit monospecific antibody (C2003) against a synthetic peptide from HIV-1 RT.
  • Immunoblot analysis of HIV-2 virus extract to assess antibody cross-reactivity.
  • Enzyme activity assays to determine the inhibitory effect of the antibody on HIV-2 RT.
  • Immunoaffinity chromatography using C2003 antibody for fractionation of HIV-2 RT.
  • Immunogenicity assessment of isolated viral proteins using human sera.

Main Results:

  • A rabbit antibody (C2003) was successfully raised against a conserved sequence in HIV-1 RT.
  • The C2003 antibody demonstrated cross-reactivity with HIV-2 RT and directly inhibited its enzymatic activity.
  • Immunoaffinity chromatography isolated two viral proteins (68 and 55 kD) from HIV-2, both possessing RT and RNAse H activities.
  • These isolated proteins were highly immunogenic and recognized by all tested human sera positive for HIV-2 antibodies.

Conclusions:

  • The generated antibody C2003 is effective against both HIV-1 and HIV-2 reverse transcriptase.
  • The conserved epitope targeted by C2003 is present in key viral proteins of HIV-2.
  • The study successfully identified and characterized immunogenic viral proteins associated with HIV-2 RT and RNAse H activity.